BridgeMD
New treatment option for Takotsubo Cardiomyopathy
Official title Psychosocial Support for Patients With Takotsubo Syndrome
ClinicalTrials.gov ID: NCT05977049
What this study is testing
- What it's testing
- The study hypothesis is that participants enrolled in a virtual Takotsubo support group will have significantly less anxiety at one year.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \- All patients with documented diagnosis of Takotsubo Syndrome greater than 18 years old.
You likely can't join if
- Patients with a diagnosis of Takotsubo Syndrome already undergoing Psychotherapy or those who choose not to participate.
- Vulnerable populations such as prisoners, non-English speaking people, pregnant women, and people unable to provide written informed consent will not...
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.